Article in Diabetes, obesity & metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Hood ThabitCentre for Biological Timing, Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-6076-6997
Charlotte BoughtonWellcome -MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0003-3272-9544
Womba MubitaDivision of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Jose RubioDivision of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0001-7854-4233
Parth NarendranUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Mark EvansWellcome -MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0001-8122-8987
Lalantha LeelarathnaCentre for Biological Timing, Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-9602-1962
Malgorzata E WilinskaWellcome -MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Catherine FullwoodResearch & Innovation, Manchester University NHS Foundation Trust, Manchester, UK.
Alice M GregoryDepartment of Psychology, Goldsmiths, University of London, London, UK.
Roman HovorkaWellcome -MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Martin K RutterCentre for Biological Timing, Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Funding
24/7 closed-loop in older subjects with type 1 diabetesDP3DK112176 · NIDDK · UNIVERSITY OF CAMBRIDGE · PI HOVORKA, ROMAN · 2016 to 2016
$1.9M
Medical Research Council MR/T023899/1NIDDK NIH HHS DP3 DK112176
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes. · full record | OpenQuestion